Search Within

Renier J Brentjens

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (24)
  2. Meeting Abstract (21)
  3. Editorial (1)
  4. Research Letter (1)
Groups
  1. Adult Leukemia (47)
  2. Center for Hematologic Malignancies (47)
  3. Department of Medicine (47)
  4. Epidemiology and Biostatistics (47)
  5. GSK Faculty (47)
  6. Hematologic Malignancies Research (47)

More Groups

People
  1. Jae Park (33)
  2. Elizabeth Halton (24)
  3. Isabelle Riviere (23)
  4. Michel Sadelain (23)
  5. Sean Devlin (20)
  6. Craig Sauter (19)

More People

Years
  1. 2025 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (9)
  5. 2020 (6)
  6. 2019 (10)

More Years

Publications
  1. Blood (15)
  2. Journal of Clinical Oncology (4)
  3. Biology of Blood and Marrow Transplantation (3)
  4. Blood Advances (3)
  5. Bone Marrow Transplantation (3)
  6. Nature Medicine (3)

More Publications

Publishers
  1. American Society of Hematology (18)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (4)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (4)
  6. Amer Soc Clinical Investigation Inc (1)

More Publishers

Results (47)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
    Meeting Abstract

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Clinical factors associated with improved survival following allogeneic HSCT after CD19 CAR therapy in adult patients with relapsed B-ALL
    Meeting Abstract

    Park, J. H.; Flynn, J.; Gonen, M.; Bernal, Y.; Diamonte, C.; Halton, E.; Wang, X.; Riviere, I.; Sadelain, M.; Brentjens, R. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Hematological count recovery in patients undergoing treatment with chimeric antigen receptor T cells (CAR T)
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Maloy, M. A.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Toxicity and response after CD19-specific CAR T-cell therapy in pediatric/young adult relapsed/refractory B-ALL
    Journal Article

    Curran, K. J.; Margossian, S. P.; Kernan, N. A.; Silverman, L. B.; Williams, D. A.; Shukla, N.; Kobos, R.; Forlenza, C. J.; Steinherz, P.; Prockop, S.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Impact of bridging chemotherapy on clinical outcome of CD19 CAR T therapy in adult ALL
    Meeting Abstract

    Perica, K.; Flynn, J.; Curran, K. J.; Wang, X.; Halton, E.; Diamonte, C.; Pineda, J.; Bernal, Y.; Gonen, M.; Riviere, I.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma
    Journal Article

    Sauter, C. S.; Senechal, B.; RivieĢ€re, I.; Ni, A.; Bernal, Y.; Wang, X.; Purdon, T.; Hall, M.; Singh, A. N.; Szenes, V. Z.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Resource utilization within 30 days of car T cells for hematologic malignancies
    Meeting Abstract

    Shah, G.; Park, J.; Sauter, C.; Duck, E.; Halton, E.; Batlevi, C.; Palomba, M. L.; Younes, A.; Geyer, M.; Smith, E.; more...
    Value in Health (2019)

    Fulltext@MSK | Save
  • Safety and tolerability of conditioning chemotherapy followed by CD19-targeted CAR T cells for relapsed/refractory CLL
    Journal Article

    Geyer, M. B.; Riviere, I.; Senechal, B.; Wang, X.; Wang, Y.; Purdon, T. J.; Hsu, M.; Devlin, S. M.; Palomba, M. L.; Halton, E.; more...
    JCI Insight (2019)

    Fulltext@MSK | Save
  • CAR T cells secreting an immune checkpoint blockade scFv have enhanced anti-tumor efficacy
    Meeting Abstract

    Rafiq, S.; Yeku, O.; Jackson, H.; Purdon, T.; van Leeuwen, D.; Yan, S.; Wang, P.; Xiang, J.; Liu, C.; Seshan, V.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save